BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3695939)

  • 21. Complementation of transformed fibroblasts from patients with combined xeroderma pigmentosum-Cockayne syndrome.
    Ellison AR; Nouspikel T; Jaspers NG; Clarkson SG; Gruenert DC
    Exp Cell Res; 1998 Aug; 243(1):22-8. PubMed ID: 9716445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human cells deficient in transcription-coupled repair show prolonged activation of the Jun N-terminal kinase and increased sensitivity following cisplatin treatment.
    Bulmer JT; Zacal NJ; Rainbow AJ
    Cancer Chemother Pharmacol; 2005 Aug; 56(2):189-98. PubMed ID: 15841377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formation and repair of cisplatin-induced adducts to DNA in cultured normal and repair-deficient human fibroblasts.
    Dijt FJ; Fichtinger-Schepman AM; Berends F; Reedijk J
    Cancer Res; 1988 Nov; 48(21):6058-62. PubMed ID: 3167856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced capacity to repair irradiated adenovirus in fibroblasts from xeroderma pigmentosum heterozygotes.
    Rainbow AJ
    Cancer Res; 1980 Nov; 40(11):3945-9. PubMed ID: 7471045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disruption of the mouse xeroderma pigmentosum group D DNA repair/basal transcription gene results in preimplantation lethality.
    de Boer J; Donker I; de Wit J; Hoeijmakers JH; Weeda G
    Cancer Res; 1998 Jan; 58(1):89-94. PubMed ID: 9426063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of matrix metalloproteinase 1 in dermal fibroblasts from DNA repair-deficient/cancer-prone xeroderma pigmentosum group C patients.
    Fréchet M; Warrick E; Vioux C; Chevallier O; Spatz A; Benhamou S; Sarasin A; Bernerd F; Magnaldo T
    Oncogene; 2008 Sep; 27(39):5223-32. PubMed ID: 18469853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultraviolet hypermutability of a shuttle vector propagated in xeroderma pigmentosum variant cells.
    Waters HL; Seetharam S; Seidman MM; Kraemer KH
    J Invest Dermatol; 1993 Nov; 101(5):744-8. PubMed ID: 8228338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of microsatellite instability in a cell line from a patient with xeroderma pigmentosum variant.
    Tzung TY; Diem C; Rünger TM
    Arch Dermatol Res; 1998 Mar; 290(3):109-12. PubMed ID: 9558484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular cloning of a mouse DNA repair gene that complements the defect of group-A xeroderma pigmentosum.
    Tanaka K; Satokata I; Ogita Z; Uchida T; Okada Y
    Proc Natl Acad Sci U S A; 1989 Jul; 86(14):5512-6. PubMed ID: 2748601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deficient gene specific repair of cisplatin-induced lesions in Xeroderma pigmentosum and Fanconi's anemia cell lines.
    Zhen W; Evans MK; Haggerty CM; Bohr VA
    Carcinogenesis; 1993 May; 14(5):919-24. PubMed ID: 8504485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An SV40-transformed xeroderma pigmentosum group D cell line: establishment, ultraviolet sensitivity, transfection efficiency and plasmid mutation induction.
    Protić-Sabljić M; Seetharam S; Seidman MM; Kraemer KH
    Mutat Res; 1986 Nov; 166(3):287-94. PubMed ID: 3023995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutational hotspot variability in an ultraviolet-treated shuttle vector plasmid propagated in xeroderma pigmentosum and normal human lymphoblasts and fibroblasts.
    Seetharam S; Kraemer KH; Waters HL; Seidman MM
    J Mol Biol; 1990 Apr; 212(3):433-6. PubMed ID: 2182882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complementation of DNA repair in xeroderma pigmentosum group A cell extracts by a protein with affinity for damaged DNA.
    Robins P; Jones CJ; Biggerstaff M; Lindahl T; Wood RD
    EMBO J; 1991 Dec; 10(12):3913-21. PubMed ID: 1935910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reactivation of psoralen-reacted plasmid DNA in Fanconi anemia, xeroderma pigmentosum, and normal human fibroblast cells.
    Sun Y; Moses RE
    Somat Cell Mol Genet; 1991 May; 17(3):229-38. PubMed ID: 2047939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transformation of DNA repair-deficient human diploid fibroblasts with a simian virus 40 plasmid.
    Wood CM; Timme TL; Hurt MM; Brinkley BR; Ledbetter DH; Moses RE
    Exp Cell Res; 1987 Apr; 169(2):543-53. PubMed ID: 3030788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Xeroderma pigmentosum group E cells lack a nuclear factor that binds to damaged DNA.
    Chu G; Chang E
    Science; 1988 Oct; 242(4878):564-7. PubMed ID: 3175673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Restricted ultraviolet mutational spectrum in a shuttle vector propagated in xeroderma pigmentosum cells.
    Bredberg A; Kraemer KH; Seidman MM
    Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8273-7. PubMed ID: 3464953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microcell-mediated transfer of a single human chromosome complements xeroderma pigmentosum group A fibroblasts.
    Schultz RA; Saxon PJ; Glover TW; Friedberg EC
    Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4176-9. PubMed ID: 3035572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Xeroderma pigmentosum. A gene for tumour prevention.
    Wood RD; Lindahl T
    Nature; 1990 Nov; 348(6296):13-4. PubMed ID: 2234052
    [No Abstract]   [Full Text] [Related]  

  • 40. Frequencies of mutagenic translesion DNA synthesis over cisplatin-guanine intra-strand crosslinks in lacZ plasmids propagated in human cells.
    Fujikawa Y; Kawanishi M; Kuraoka I; Yagi T
    Mutat Res Genet Toxicol Environ Mutagen; 2014 Aug; 770():23-8. PubMed ID: 25344160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.